Insider · CIK 0001295744
Susan M Lyne
Files at GPRO (GoPro, Inc.), SRTA (Strata Critical Medical, Inc.). First filing -, latest -.
Susan M Lyne files SEC Form 4 as director at GPRO (GoPro, Inc.), and also at SRTA (Strata Critical Medical, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Susan M Lyne has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | GPRO GoPro, Inc. | AGrant or award Class A Common Stock | +110,181 | $0.00 | $0 | 449,100 | Jun 4, 2026 |
| Aug 1, 2025 | SRTA Strata Critical Medical, Inc. | AGrant or award Class A common stock, $0.0001 par value per share | +35,534 | $0.00 | $0 | 187,185 | Aug 5, 2025 |
| Jun 3, 2025 | GPRO GoPro, Inc. | AGrant or award Class A Common Stock | +127,358 | $0.00 | $0 | 338,919 | Jun 5, 2025 |
Questions about Susan M Lyne
Answered from the filings on this page, as of the latest one.
Is Susan M Lyne buying or selling?
Susan M Lyne has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Susan M Lyne's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Susan M Lyne has 0.
Where does Susan M Lyne file Form 4?
Susan M Lyne has filed Form 4 at GPRO (GoPro, Inc.); SRTA (Strata Critical Medical, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.